AN2 Therapeutics, Inc. (ANTX)
4.94
-0.50
(-9.19%)
USD |
NASDAQ |
Mar 13, 16:00
4.95
+0.01
(+0.20%)
After-Hours: 20:00
AN2 Therapeutics Total Assets (Quarterly) : 67.24M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Relmada Therapeutics, Inc. | 14.88M |
| ACADIA Pharmaceuticals, Inc. | 1.564B |
| Alnylam Pharmaceuticals, Inc. | 5.026B |
| Savara, Inc. | 253.44M |
| BioMarin Pharmaceutical, Inc. | 7.594B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 6.858M |
| Shareholders Equity (Quarterly) | 60.38M |
| Current Ratio | 9.334 |